Supreme Court 7-2 Ruling Preempts State Failure-to-Warn Claims in Glyphosate Litigation

{"The decision rests on federal preemption doctrine, finding EPA’s 2017-2022 risk assessments—which concluded glyphosate is not likely carcinogenic when used as directed—control over conflicting state tort duties. Durnell’s non-Hodgkin lymphoma claim after two decades of residential spraying was the test case. Bayer, which inherited 200,000 claims via the 2018 Monsanto acquisition, now expects dismissal of most failure-to-warn counts while continuing its proposed $7.25 billion class settlement.","IARC’s 2015 Group 2A classification relied on limited human evidence plus mechanistic data from animal and cell studies; EPA’s reviews incorporated registrant-submitted chronic feeding studies and epidemiology cohorts showing no consistent exposure-response relationship. No randomized trial of glyphosate exposure exists. The ruling narrows plaintiffs’ path but leaves design-defect or manufacturing claims potentially viable under the same federal framework.","The outcome collides with the administration’s “Make America Healthy Again” pesticide-reduction agenda, exposing tension between regulatory certainty for agriculture and tort-based accountability. Three states have already enacted liability shields. Bayer has removed glyphosate from U.S. residential products yet defends agricultural uses that account for most volume. Environmental groups argue the decision reduces incentives for post-approval safety data.","Next steps hinge on Missouri state-court approval of the class settlement and any remaining non-preempted claims. Observational cohorts with better exposure metrics and longer latency tracking are required before regulatory classification shifts."}